Protocols
IIT-HALL-MRI-ENHANCE Phase I OPEN TO ACCRUAL
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
REGENERON-R7075-ONC-2009 Phase I/II OPEN TO ACCRUAL
A Phase 1/2 Study of REGN7075 (EGFRxCD28 Costimulatory Bispecific Antibody) in Combination with Cemiplimab in Patients with Advanced Solid Tumors